Company Filing History:
Years Active: 2024
Title: Innovations by Sherman Michael Chin in Immune Modulation
Introduction
Sherman Michael Chin is an accomplished inventor based in Burlingame, California. He has made significant contributions to the field of immunology through his groundbreaking patents that focus on modulating immune cell functions, particularly targeting CD8+ T cells. His work is crucial for developing therapeutic strategies in various diseases, including cancer and autoimmune disorders.
Latest Patents
Sherman's notable patent is titled "Fusions with CD8 antigen binding molecules for modulating immune cell function." This patent encompasses anti-CD8 antigen binding molecules and fusion polypeptides designed to selectively enhance the function of CD8+ T cells while sparing other immune cells. Additionally, the patent provides detailed methodologies for producing these innovative molecules, along with pharmaceutical compositions that incorporate them. The technology outlined in the patent also includes polynucleotides encoding the antigen binding molecules and methods of their use, marking a significant advancement in immunotherapeutic approaches.
Career Highlights
Sherman is currently affiliated with Asher Biotherapeutics, Inc., where he continues to explore novel approaches to immune modulation. His dedication to advancing the understanding of immune functions through innovative research positions him at the forefront of biotherapeutic development.
Collaborations
At Asher Biotherapeutics, Sherman collaborates with talented colleagues like Yik Andy Yeung and Ivana Djuretic, further enhancing the company's research endeavors. These collaborations are pivotal in driving forward the innovative work being done in the laboratory, showcasing the power of teamwork in scientific discovery.
Conclusion
Sherman Michael Chin's contributions to the field of immunology through his patent on CD8 antigen binding molecules represent a significant leap forward in therapeutic interventions. His innovative work at Asher Biotherapeutics highlights the importance of research and collaboration among talented scientists in shaping the future of medicine. With continued efforts in this domain, Sherman is likely to make even more impactful advancements in immune modulation.